Luna Innovations Reports Solid Second-Quarter 2020 Results
Maintains 2020 Outlook
Highlights
- Total revenues of $18.6 million for the three months ended June 30, 2020, up 4% compared to the three months ended June 30, 2019
- Operating income and margin of $1.8 million and 10% of total revenues, for the three months ended June 30, 2020 versus operating income and margin of $1.0 million and 6% of total revenues, for the three months ended June 30, 2019
- Net income of $1.4 million, or $0.04 per fully diluted share, for the three months ended June 30, 2020, compared to $0.8 million, or $0.02 per fully diluted share, for the three months ended June 30, 2019
- Adjusted EBITDA increased to $3.0 million for the three months ended June 30, 2020, compared to $2.4 million for the three months ended June 30, 2019
- Company maintains 2020 outlook, tightens revenue range to $81M to $83M
(ROANOKE, VA, August 6, 2020) - Luna Innovations Incorporated (NASDAQ: LUNA), a global leader in advanced optical technology, today announced its financial results for the three and six months ended June 30, 2020. During the second quarter of 2020, the company changed its reportable segments to align with how management reviews and evaluates the business. The two new reportable segments are Lightwave and Luna Labs.
"Given the current environment, I’m extremely pleased with our second-quarter 2020 results and the team’s focus on delivering this quarter,” said Scott Graeff, President and Chief Executive Officer of Luna. “Like other companies, we experienced the effects of the COVID-19 pandemic during Q2 and now have a better perspective on what its impact may be in the future. I strongly believe that the swift and decisive action we took as a management team in mid-March helped to safeguard the long-term potential of our businesses. The entire Luna team continues to be incredibly flexible to address the changing dynamics of the current environment. Above all, their safety is paramount. As we learn more about the potential impact of this virus on our business and our employee safety, we continue to improve upon the mitigating processes we put into place in Q1."
Second-Quarter Fiscal 2020 Financial Summary
Financial results for the three months ended June 30, 2020 marked the 11th consecutive quarter of year-on-year revenue and Adjusted EBITDA growth.
Highlights of the financial results for the second-quarter of 2020 are:
|
|
|
|
Three Months Ended June 30, |
|
|
|
|||||||
|
(in thousands, except share and per share data) |
|
2020 |
|
2019 |
|
Change |
|||||||
|
Revenues: |
|
|
|
|
|
||||||||
|
Lightwave |
|
$ |
12,933 |
|
|
$ |
12,523 |
|
|
3 |
|
% |
|
|
Luna Labs |
|
5,643 |
|
|
5,291 |
|
|
7 |
|
% |
|||
|
|
Total revenues |
|
18,576 |
|
|
17,814 |
|
|
4 |
|
% |
||
|
|
|
|
|
|
|
|
|
||||||
|
Gross profit |
|
9,517 |
|
|
8,752 |
|
|
9 |
|
% |
|||
|
Gross margin |
|
51 |
% |
|
49 |
% |
|
|
|||||
|
|
|
|
|
|
|
|
|||||||
|
Operating expense |
|
7,707 |
|
|
7,738 |
|
|
— |
|
% |
|||
|
Operating income |
|
1,810 |
|
|
1,014 |
|
|
79 |
|
% |
|||
|
Operating margin |
|
10 |
% |
|
6 |
% |
|
|
|
||||
|
|
|
|
|
|
|
|
|||||||
|
Other expense and income taxes |
|
(441) |
|
|
(174) |
|
|
153 |
|
% |
|||
|
|
|
|
|
|
|
|
|
||||||
|
Net income |
|
$ |
1,369 |
|
|
$ |
840 |
|
|
63 |
|
% |
|
|
Diluted weighted average shares outstanding |
|
32,466,122 |
|
|
33,650,790 |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||
|
Net income per share (diluted) |
|
$ |
0.04 |
|
|
$ |
0.02 |
|
|
100 |
|
% |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Adjusted EBITDA |
|
$ |
2,955 |
|
|
$ |
2,396 |
|
|
23 |
|
% |
|
A reconciliation of Adjusted EBITDA to net income can be found in the schedules included in this release.
Lightwave revenues for the three months ended June 30, 2020 increased compared to the prior year period, due primarily to increased revenues from our sensing business. Luna Labs revenue increased for the three months ended June 30, 2020, compared to the prior-year period, due to growth in various government research programs.
Operating income and margin improved to $1.8 million and 10% of total revenues, for the three months ended June 30, 2020, compared to $1.0 million and 6% of total revenues, for the three months ended June 30, 2019. The increase in operating income was primarily due to Lightwave's increased gross profit. There were no significant changes in operating expenses for the three months ended June 30, 2020, compared to the three months ended June 30, 2019.
Net income was $1.4 million, or $0.04 per fully diluted share, for the three months ended June 30, 2020, compared to $0.8 million, or $0.02 per fully diluted share, for the three months ended June 30, 2019. Net income attributable to common stockholders for the three months ended June 30, 2020, was $1.4 million, or $0.04 per fully diluted share, compared to $0.8 million, or $0.02 per fully diluted share, for the three months ended June 30, 2019. The increase in both net income from continuing operations and net income attributable to common stockholders is primarily due to Lightwave's additional gross profit and operating expense leverage.
Adjusted EBITDA was $3.0 million for the three months ended June 30, 2020, compared to $2.4 million for the three months ended June 30, 2019. The increase was driven by revenue growth from both Luna’s legacy business, increased gross profit, and operating expense leverage.
Six Months Year-to-Date Fiscal 2020 Financial Summary
The results for the six months ended June 30, 2020 include six months of the business of General Photonics Corporation ("GP"), acquired in March 2019, compared to four months for the prior-year period.
Highlights of the financial results for the six months ended June 30, 2020 are:
|
|
|
|
Six Months Ended June 30, |
|
|
|
|||||||
|
(in thousands, except share and per share data) |
|
2020 |
|
2019 |
|
Change |
|||||||
|
Revenues: |
|
|
|
|
|
||||||||
|
Lightwave |
|
$ |
24,487 |
|
|
$ |
22,041 |
|
|
11 |
|
% |
|
|
Luna Labs |
|
11,230 |
|
|
10,606 |
|
|
6 |
|
% |
|||
|
|
Total revenues |
|
35,717 |
|
|
32,647 |
|
|
9 |
|
% |
||
|
|
|
|
|
|
|
|
|
||||||
|
Gross profit |
|
17,881 |
|
|
15,520 |
|
|
15 |
|
% |
|||
|
Gross margin |
|
50 |
% |
|
48 |
% |
|
|
|||||
|
|
|
|
|
|
|
|
|||||||
|
Operating expense |
|
15,681 |
|
|
15,422 |
|
|
2 |
|
% |
|||
|
Operating income |
|
2,200 |
|
|
98 |
|
|
2,145 |
|
% |
|||
|
Operating margin |
|
6 |
% |
|
0 |
% |
|
|
|
||||
|
|
|
|
|
|
|
|
|||||||
|
Other (expense)/income and income taxes |
|
(511) |
|
|
1,869 |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||
|
Net income from continuing operations |
|
$ |
1,689 |
|
|
$ |
1,967 |
|
|
(14) |
|
% |
|
|
|
|
|
|
|
|
|
|
||||||
|
Loss from discontinued operations, net of income tax of $464 |
|
(1,436) |
|
|
— |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||
|
Net income |
|
253 |
|
|
1,967 |
|
|
(87) |
|
% |
|||
|
Diluted weighted average shares outstanding |
|
32,494,950 |
|
|
33,588,951 |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||
|
Net income per share from continuing operations (diluted) |
|
$ |
0.05 |
|
|
$ |
0.06 |
|
|
(17) |
|
% |
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Adjusted EBITDA |
|
$ |
4,535 |
|
|
$ |
3,335 |
|
|
36 |
|
% |
|
Lightwave revenues for the six months ended June 30, 2020 increased compared to the prior year period due to the inclusion of the incremental revenues associated with the acquired operations of GP, as well as increased revenues associated with our sensing business. Luna Labs revenues increased for the six months ended June 30, 2020, compared to the prior period, due to growth in various government research programs.
Operating income and margin improved to $2.2 million and 6% of total revenues, for the six months ended June 30, 2020, compared to $0.1 million and 0% of total revenues, in six months ended June 30, 2019. The increase in operating income is primarily due to increased growth from the acquired operations of GP and operating expense leverage.
Net income from continuing operations was $1.7 million, or $0.05 per fully diluted share, for the six months ended June 30, 2020, compared to $2.0 million, or $0.06 per fully diluted share, for the six months ended June 30, 2019, which included a $1.9 million income tax benefit related to a reduction in deferred tax asset valuation allowances due to the GP acquisition. Net income attributable to common stockholders for the six months ended June 30, 2020, was $0.3 million, or $0.01 per fully diluted share, compared to $1.8 million, or $0.05 per fully diluted share, for the six months ended June 30, 2019. The decrease in net income attributable to common stockholders is primarily due to a $1.9 million income tax benefit related to a reduction in deferred tax asset valuation allowances due to the GP acquisition that was recorded in the prior period, a $1.4 million loss from discontinued operations and the increase in our operating income for the six months ended June 30, 2020. The loss from discontinued operations was attributable to the resolution of a $2.5 million indemnification claim related to the August 2017 sale of Luna's high-speed optical receivers (HSOR) business that was recorded in the first quarter of 2020. The resolution of the HSOR claim resulted in Luna receiving $0.6 million from escrow and the buyer receiving $1.9 million, net of a tax benefit of $0.5 million.
2020 Full-Year Outlook
Luna recognizes that the COVID-19 pandemic has created evolving and significant macroeconomic uncertainty. Based on a bottoms-up analysis, Luna is slightly tightening its revenue outlook range to $83 million. Incorporating this slight adjustment, the Company reiterates the outlook it provided on May 7, 2020, which projected revenues at the lower end of the range:
• Total revenues of $81M to $83M
• Adjusted EBITDA of $10M to $12M
COVID-19 Update
Luna continues to operate at its normal capacity with the well-being and safety of its workforce a priority. Luna and has not experienced any material impacts related to COVID-19.
Luna has a strong cash position and adequate access to capital. Cash and cash equivalents were $26.5 million as of June 30, 2020, and Luna continues to have access to its $10 million revolving credit facility.
The company believes it is in a strong position to take advantage of trends such as 5G, lightweighting and infrastructure monitoring and that these trends will continue during and after the COVID-19 pandemic.
Luna’s operations are essential and continue to operate at normal capacity with necessary COVID-19 precautions. The company has not experienced any material disruptions to its supply chain that it has not been able to mitigate.
An important part of Luna’s sales effort has been done historically through a series of tradeshows and conferences, none of which are currently taking place. Luna's successful shift to a robust online presence has, in many instances, improved engagement between Luna's sales force and its customers, allowing Luna to curate a specific message over a longer and more dedicated period of customer "face time". Yet, in-person meetings have historically been helpful in closing the sale. This has created a slight challenge around Luna's ability to forecast the exact timing of closing certain customer contracts and receiving purchase orders. Due to Luna's innovative, reliable products and its close customer relationships, the lack of in-person discussions has not, to date, had an effect on the likelihood of obtaining the orders themselves.
Non-GAAP Financial Measures
In evaluating the operating performance of its business, Luna’s management considers Adjusted EBITDA, which excludes certain charges and credits that are required by GAAP. Adjusted EBITDA provides useful information to both management and investors by excluding the effect of certain non-cash expenses and items that Luna believes may not be indicative of its operating performance, because either they are unusual and Luna does not expect them to recur in the ordinary course of its business, or they are unrelated to the ongoing operation of the business in the ordinary course. Adjusted EBITDA should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. Adjusted EBITDA has been reconciled to the nearest GAAP measure in the table following the financial statements attached to this press release.
Conference Call Information
As previously announced, Luna will conduct an investor conference call at 5:00 pm (ET) today to discuss its financial results for the three and six months ended June 30, 2020. The investor conference call will be available via live webcast on the Luna website at www.lunainc.com under the tab “Investor Relations.” To participate by telephone, the domestic dial-in number is 844.578.9643 and the international dial-in number is 270.823.1522. The participant access code is 8888351. Investors are advised to dial in at least five minutes prior to the call to register. The webcast will be archived on the company’s website under “Webcasts and Presentations” for 30 days following the conference call.
About Luna
Luna Innovations Incorporated (www.lunainc.com) is a leader in optical technology, providing unique capabilities in high-performance, fiber optic-based, test products for the telecommunications industry and distributed fiber optic-based sensing for the aerospace and automotive industries. Luna is organized into two business segments, which work closely together to turn ideas into products: a Lightwave segment and a Luna Labs segment. Luna’s business model is designed to accelerate the process of bringing new and innovative technologies to market.
Forward-Looking Statements
The statements in this release that are not historical facts constitute “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements include Luna's expectations regarding its projected 2020 financial results and outlook, the strength and improvement in capital structure and the solidity of its balance sheet and cash flows, the potential impacts of the COVID-19 pandemic on its business, operations and financial results, and growth potential. Management cautions the reader that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and uncertainties, and actual results, performance, and/or achievements of Luna may differ materially from the future results, performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These factors include, without limitation, failure of demand for Luna's products and services to meet expectations, failure of target market to grow and expand, technological and strategic challenges, uncertainties related to the ultimate impact of the COVID-19 pandemic and those risks and uncertainties set forth in Luna’s Form 10-Q for the three and six months ended June 30, 2020, and Luna's other periodic reports and filings with the Securities and Exchange Commission ("SEC"). Such filings are available on the SEC’s website at www.sec.gov and on Luna’s website at www.lunainc.com. The statements made in this release are based on information available to Luna as of the date of this release and Luna undertakes no obligation to update any of the forward-looking statements after the date of this release.
Investor Contact:
Allison Woody
Phone: 540-769-8465
Email: [email protected]
Luna Innovations Incorporated
Consolidated Statements of Operations (Unaudited)
(in thousands, except share and per share data)
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
||||||||||||
|
|
2020 |
|
2019 |
|
|
2020 |
|
2019 |
||||||||
|
|
|
|
|
|
||||||||||||
|
Revenues: |
|
|
|
|
|
|
|
|
||||||||
|
Lightwave |
$ |
12,933 |
|
|
$ |
12,523 |
|
|
|
$ |
24,487 |
|
|
$ |
22,041 |
|
|
Luna Labs |
5,643 |
|
|
5,291 |
|
|
|
11,230 |
|
|
10,606 |
|
||||
|
Total revenues |
18,576 |
|
|
17,814 |
|
|
|
35,717 |
|
|
32,647 |
|
||||
|
Cost of revenues: |
|
|
|
|
|
|
|
|
||||||||
|
Lightwave |
5,181 |
|
|
5,334 |
|
|
|
10,066 |
|
|
9,613 |
|
||||
|
Luna Labs |
3,878 |
|
|
3,728 |
|
|
|
7,770 |
|
|
7,514 |
|
||||
|
Total cost of revenues |
9,059 |
|
|
9,062 |
|
|
|
17,836 |
|
|
17,127 |
|
||||
|
Gross profit |
9,517 |
|
|
8,752 |
|
|
|
17,881 |
|
|
15,520 |
|
||||
|
Operating expense: |
|
|
|
|
|
|
|
|
||||||||
|
Selling, general and administrative |
6,202 |
|
|
6,003 |
|
|
|
12,579 |
|
|
12,229 |
|
||||
|
Research, development and engineering |
1,505 |
|
|
1,735 |
|
|
|
3,102 |
|
|
3,193 |
|
||||
|
Total operating expense |
7,707 |
|
|
7,738 |
|
|
|
15,681 |
|
|
15,422 |
|
||||
|
Operating income |
1,810 |
|
|
1,014 |
|
|
|
2,200 |
|
|
98 |
|
||||
|
Other income/(expense): |
|
|
|
|
|
|
|
|
||||||||
|
Investment income |
4 |
|
|
77 |
|
|
|
64 |
|
|
268 |
|
||||
|
Other (expense)/income |
(4) |
|
|
(3) |
|
|
|
5 |
|
|
(4) |
|
||||
|
Interest expense |
(1) |
|
|
— |
|
|
|
(1) |
|
|
(13) |
|
||||
|
Total other (expense)/income |
(1) |
|
|
74 |
|
|
|
68 |
|
|
251 |
|
||||
|
Income from continuing operations before income taxes |
1,809 |
|
|
1,088 |
|
|
|
2,268 |
|
|
349 |
|
||||
|
Income tax expense/(benefit) |
440 |
|
|
247 |
|
|
|
579 |
|
|
(1,618) |
|
||||
|
Net income from continuing operations |
1,369 |
|
|
841 |
|
|
|
1,689 |
|
|
1,967 |
|
||||
|
Loss from discontinued operations, net of income tax of $464 |
— |
|
|
— |
|
|
|
(1,436) |
|
|
— |
|
||||
|
Net income |
1,369 |
|
|
841 |
|
|
|
253 |
|
|
1,967 |
|
||||
|
Preferred stock dividend |
— |
|
|
90 |
|
|
|
— |
|
|
173 |
|
||||
|
Net income attributable to common stockholders |
$ |
1,369 |
|
|
$ |
751 |
|
|
|
$ |
253 |
|
|
$ |
1,794 |
|
|
Net income per share from continuing operations: |
|
|
|
|
|
|
|
|
||||||||
|
Basic |
$ |
0.04 |
|
|
$ |
0.03 |
|
|
|
$ |
0.06 |
|
|
$ |
0.07 |
|
|
Diluted |
$ |
0.04 |
|
|
$ |
0.02 |
|
|
|
$ |
0.05 |
|
|
$ |
0.06 |
|
|
Net loss per share from discontinued operations: |
|
|
|
|
|
|
|
|
||||||||
|
Basic |
$ |
— |
|
|
$ |
— |
|
|
|
$ |
(0.05) |
|
|
$ |
— |
|
|
Diluted |
$ |
— |
|
|
$ |
— |
|
|
|
$ |
(0.04) |
|
|
$ |
— |
|
|
Net income per share attributable to common stockholders: |
|
|
|
|
|
|
|
|
||||||||
|
Basic |
$ |
0.04 |
|
|
$ |
0.03 |
|
|
|
$ |
0.01 |
|
|
$ |
0.06 |
|
|
Diluted |
$ |
0.04 |
|
|
$ |
0.02 |
|
|
|
$ |
0.01 |
|
|
$ |
0.05 |
|
|
Weighted average shares: |
|
|
|
|
|
|
|
|
||||||||
|
Basic |
30,589,249 |
|
|
28,246,840 |
|
|
|
30,484,797 |
|
|
28,143,534 |
|
||||
|
Diluted |
32,466,122 |
|
|
33,650,790 |
|
|
|
32,494,950 |
|
|
33,588,951 |
|
||||
Consolidated Balance Sheets
(in thousands, except share data)
|
|
June 30, 2020 |
|
December 31, 2019 |
||||
|
|
(unaudited) |
|
|
||||
|
Assets |
|
|
|
||||
|
Current assets: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
26,506 |
|
|
$ |
25,006 |
|
|
Accounts receivable, net |
16,435 |
|
|
16,269 |
|
||
|
Receivable from sale of HSOR business |
— |
|
|
2,501 |
|
||
|
Contract assets |
3,220 |
|
|
2,759 |
|
||
|
Inventory |
11,231 |
|
|
10,294 |
|
||
|
Prepaid expenses and other current assets |
1,691 |
|
|
1,287 |
|
||
|
Total current assets |
59,083 |
|
|
58,116 |
|
||
|
Long-term contract assets |
496 |
|
|
449 |
|
||
|
Property and equipment, net |
3,078 |
|
|
3,466 |
|
||
|
Intangible assets, net |
9,544 |
|
|
10,194 |
|
||
|
Goodwill |
10,542 |
|
|
10,542 |
|
||
|
Other assets |
7,053 |
|
|
2,341 |
|
||
|
Deferred tax asset |
1,426 |
|
|
1,416 |
|
||
|
Total assets |
$ |
91,222 |
|
|
$ |
86,524 |
|
|
Liabilities and stockholders’ equity |
|
|
|
||||
|
Liabilities: |
|
|
|
||||
|
Current liabilities: |
|
|
|
||||
|
Accounts payable |
2,763 |
|
|
2,787 |
|
||
|
Accrued liabilities |
8,150 |
|
|
10,369 |
|
||
|
Contract liabilities |
3,368 |
|
|
3,888 |
|
||
|
Total current liabilities |
14,281 |
|
|
17,044 |
|
||
|
Other long-term liabilities |
7,140 |
|
|
2,011 |
|
||
|
Total liabilities |
21,421 |
|
|
19,055 |
|
||
|
Commitments and contingencies (Note 13) |
|
|
|
||||
|
Stockholders’ equity: |
|
|
|
||||
|
Common stock, par value $0.001, 100,000,000 shares authorized, 32,470,276 and 31,788,896 shares issued, 30,797,535 and 30,149,105 shares outstanding at June 30, 2020 and December 31, 2019, respectively |
32 |
|
|
32 |
|
||
|
Treasury stock at cost, 1,672,741 and 1,639,791 shares at June 30, 2020 and December 31, 2019, respectively |
(4,541) |
|
|
(4,337) |
|
||
|
Additional paid-in capital |
90,305 |
|
|
88,022 |
|
||
|
Accumulated deficit |
(15,995) |
|
|
(16,248) |
|
||
|
Total stockholders’ equity |
69,801 |
|
|
67,469 |
|
||
|
Total liabilities and stockholders’ equity |
$ |
91,222 |
|
|
$ |
86,524 |
|
Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
|
|
Six Months Ended June 30, |
||||||
|
|
2020 |
|
2019 |
||||
|
|
|
||||||
|
Cash flows provided by operating activities |
|
|
|
||||
|
Net income |
$ |
253 |
|
|
$ |
1,967 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities |
|
|
|
||||
|
Depreciation and amortization |
1,363 |
|
|
1,166 |
|
||
|
Share-based compensation |
843 |
|
|
721 |
|
||
|
Bad debt expense |
(26) |
|
|
— |
|
||
|
Loss on disposal of fixed assets |
4 |
|
|
— |
|
||
|
Loss from discontinued operations, net of tax |
1,436 |
|
|
— |
|
||
|
Deferred taxes |
(10) |
|
|
— |
|
||
|
Change in assets and liabilities |
|
|
|
||||
|
Accounts receivable |
(139) |
|
|
713 |
|
||
|
Contract assets |
(508) |
|
|
(721) |
|
||
|
Inventory |
(937) |
|
|
(161) |
|
||
|
Other current assets |
(404) |
|
|
(18) |
|
||
|
Accounts payable and accrued expenses |
(1,286) |
|
|
(2,314) |
|
||
|
Contract liabilities |
(520) |
|
|
(235) |
|
||
|
Net cash provided by operating activities |
69 |
|
|
1,118 |
|
||
|
Cash flows provided by/(used in) investing activities |
|
|
|
||||
|
Acquisition of property and equipment |
(111) |
|
|
(406) |
|
||
|
Intangible property costs |
(192) |
|
|
(137) |
|
||
|
Acquisition of General Photonics Corporation |
— |
|
|
(19,004) |
|
||
|
Proceeds from sale of property and equipment |
1 |
|
|
— |
|
||
|
Proceeds from sale of discontinued operations |
600 |
|
|
— |
|
||
|
Net cash provided by/(used in) investing activities |
298 |
|
|
(19,547) |
|
||
|
Cash flows provided by/(used in) financing activities |
|
|
|
||||
|
Payments on finance lease obligations |
(26) |
|
|
(15) |
|
||
|
Payments of debt obligations |
— |
|
|
(625) |
|
||
|
Repurchase of common stock |
(204) |
|
|
(220) |
|
||
|
Proceeds from the exercise of options and warrants |
1,363 |
|
|
367 |
|
||
|
Net cash provided by/(used in) financing activities |
1,133 |
|
|
(493) |
|
||
|
Net increase/(decrease) in cash and cash equivalents |
1,500 |
|
|
(18,922) |
|
||
|
Cash and cash equivalents-beginning of period |
25,006 |
|
|
42,460 |
|
||
|
Cash and cash equivalents-end of period |
$ |
26,506 |
|
|
$ |
23,538 |
|
Reconciliation of Net Income to EBITDA and Adjusted EBITDA (Unaudited)
(in thousands)
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
||||||||||||
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||
|
|
|
|
|
||||||||||||
|
Net income |
$ |
1,369 |
|
|
$ |
841 |
|
|
$ |
253 |
|
|
$ |
1,967 |
|
|
Loss from discontinued operations, net of tax |
— |
|
|
— |
|
|
(1,436) |
|
|
— |
|
||||
|
Net income from continuing operations |
1,369 |
|
|
841 |
|
|
1,689 |
|
|
1,967 |
|
||||
|
Interest expense |
1 |
|
|
— |
|
|
1 |
|
|
13 |
|
||||
|
Investment income |
(4) |
|
|
(77) |
|
|
(64) |
|
|
(268) |
|
||||
|
Income tax expense/(benefit) |
440 |
|
|
247 |
|
|
579 |
|
|
(1,618) |
|
||||
|
Depreciation and amortization |
684 |
|
|
653 |
|
|
1,363 |
|
|
1,166 |
|
||||
|
EBITDA |
2,490 |
|
|
1,664 |
|
|
3,568 |
|
|
1,260 |
|
||||
|
Share-based compensation |
465 |
|
|
378 |
|
|
967 |
|
|
721 |
|
||||
|
Non-recurring charges (1) |
— |
|
|
44 |
|
|
— |
|
|
942 |
|
||||
|
Amortization of inventory step-up |
— |
|
|
310 |
|
|
— |
|
|
412 |
|
||||
|
Adjusted EBITDA |
$ |
2,955 |
|
|
$ |
2,396 |
|
|
$ |
4,535 |
|
|
$ |
3,335 |
|
(1) Non-recurring charges consist of transaction-related expenses incurred during the three and six months ended June 30, 2019, related to the acquisition of General Photonics.
###